Nanoligent, the cancer nanomedicine spin-off developed at UAB and IR Sant Pau, devoted to advancing the protein-based nanomedicines developed at Ulab, has won the Santander X Award in the UAB Emprèn competition. This prestigious recognition highlights our innovative approach to targeting metastatic cancer stem cells using advanced protein nanodrugs. The award reinforces Nanoligent’s position as […]
Our former PhD student Héctor López-Laguna has received the Extraordinary Doctorate Award for his thesis entitled “Simple Biochemistry for Complex Protein-Based Materials.”This thesis presents a novel protein self-assembly technology based on divalent cations, and explores its biotechnological and biomedical applications. It was submitted in 2023 as part of the Biotechnology PhD program at the Autonomous
Dr. Ugutz Unzueta has joined the 3-days CIBER-BBN Nanomedicine Network meeting held in Zaragoza (Spain) to showcase the technological capabilities of our group and connect with other researchers within the Spanish nanomedicine network; looking forward to new collaborations and synergies.
Our predoctoral student, Ariana Rueda, has traveled to China for a 3-month internship at the laboratory of Professors Peng Chen and Xingyuan Fan, as part of her international PhD program. The Protein Chemical Biology and Bioorthogonal Chemistry Laboratory is located within the College of Chemistry and Molecular Engineering at Peking University in Beijing, China. During her stay, Ariana will focus on the recombinant
Our PhD student Lourdes Arena participated as a volunteer in the organization of the RESI Europe conference, held in Barcelona on April 1st. This opportunity arose through ABSTEC (the Association of Biotechnologists of Catalonia), of which both Lourdes and several members of our ULAB laboratory are members. The Redefining Every Stage of Investment (RESI) Conference,
Our predoctoral researcher, Lourdes Ailen Arena, has been awarded the prestigious INPhINIT 2024 predoctoral fellowship by the “la Caixa” Foundation. The ceremony took place at the main auditorium of the CosmoCaixa Museum, with the presence of various authorities, including Emilia Jordi (Director of the “la Caixa” Educational and Scholarship Area), Àngel Font (Executive Director of the CaixaResearch Institute), and Josep Tabernero (Director of the Vall d’Hebron
Our team has participated in the first meeting of all Spanish CIBER groups, held this year in Valencia to celebrate CIBER’s 10th anniversary. Dr. Unzueta, co-PI of our CIBER-BBN group, presented our work on “Rational Design of Multivalent Protein Nanoconjugates for Precision Drug Delivery in CXCR4+ Tumors.” CIBER (Centro de Investigación Biomédica en Red) is
Our project, “targeted nanoimmunotherapy against CXCR4+ leukaemic stem cells” has been awarded in the first edition of Miquel Ruttlant research grants, granted by Fundació Investigació Salut i Progress (FISP). This project focuses on the development of a new personalized therapeutic strategy based on nanoimmunotherapy for the treatment of acute myeloid leukemia (AML). The innovative approach combines
Our team was present in the 11th Annual PEGS Europe summit, the largest European event covering all aspects of protein and antibody engineering. We had the opportunity to present a poster related with our lasted published work.
Sciwellpodcast, hosted by Dr. Héctor López, Dr. Álvaro Larrán, and Dr. José Vicente Carratalá, has invited Dr. Ugutz Unzueta, the principal investigator of our team, to join their podcast to discuss careers, the current state of academia in Spain, and the motivations behind pursuing a scientific path.
